sthrn labs is launching soon. Browse the catalog, review our COAs, and inquire to order.
Tesamorelin
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) studied for its effects on GH secretion and visceral adipose tissue in preclinical research models. For research use only.
Compound information
What is Tesamorelin?
Stability information
Research highlights
Visceral adipose reduction
Research on the stabilized GHRH analog and its effect on visceral fat depots.
GH/IGF-1 axis stimulation
Studies examining endogenous growth hormone release and downstream IGF-1.
Metabolic parameter effects
Investigating lipid profile and body composition outcomes in clinical models.
GHRH structural stability
Mechanistic work on the modifications that extend the analog's half-life.
Sources & references
Metabolic effects of a growth hormone–releasing factor in patients with HIV
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension
Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men
All citations link directly to primary literature. sthrn labs does not reproduce, excerpt, or summarize article content.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
